Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health. 

Now we are currently looking for one Executive Editor for our journal. This is a great opportunity to network with and learn from experts in the same field.

IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2024 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/).  We have already established a very good Editorial Board: https://accscience.com/journal/IMO/about/editorial_board

We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope). Should you decide to serve on this position, you would be responsible for some of the following tasks depending on your availability:

1. Assisting the Editors-in-Chief with strategic planning for journal development
2. Lead and organise special issues.
3. Guide the selection of manuscripts and invite high-quality submissions.
4. Promote the journal and participate in outreach activities.

The term of the Executive Editor membership is one year and could then be renewed.

We believe that your expertise together with our rigorous editorial policies can build a high-standard journal specifically dedicated to Pharmacy and Omics research. If you are interested in becoming an Executive Editor for IMO, please send your full academic CV by 25 July 2025 and a short cover letter that details your interest and enthusiasm for the position to imo.office@accscience.sg.

Welcome to join us!

Innovative Medicines & Omics Editorial Office